Clover Health Investments (CLOV)
(Delayed Data from NSDQ)
$3.34 USD
-0.02 (-0.60%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $3.35 +0.01 (0.30%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.34 USD
-0.02 (-0.60%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $3.35 +0.01 (0.30%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Zacks News
Clover Health Investments, Corp. (CLOV) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 4.35% and 0.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Omnicell (OMCL) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Omnicell (OMCL) delivered earnings and revenue surprises of -1.18% and 2.37%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Signify Health (SGFY) Q2 Earnings Beat Estimates
by Zacks Equity Research
Signify (SGFY) delivered earnings and revenue surprises of 130% and 1.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Clover Health Investments, Corp. (CLOV) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 20.83% and 7.23%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Clover Health (CLOV) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Clover Health's (CLOV) first-quarter results are likely to reflect benefits from Clover Assistant management.
10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
10x Genomics (TXG) delivered earnings and revenue surprises of -2.70% and 1.21%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Omnicell (OMCL) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Omnicell (OMCL) delivered earnings and revenue surprises of 16.90% and 0.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
UnitedHealth (UNH) to Post Q1 Earnings: What to Expect
by Zacks Equity Research
UnitedHealth Group's (UNH) first-quarter results are likely to reflect the benefits of improving premiums and products.
Universal Health (UHS) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Universal Health Services' (UHS) fourth-quarter results are likely to reflect the benefits of improving patient volumes.
Mednax (MD) to Post Q4 Earnings: Here's What You Need to Know
by Zacks Equity Research
Mednax's (MD) fourth-quarter results are likely to reflect growth in same-unit revenues and NICU days.
Will Patient Days Drive Community Health (CYH) Q4 Earnings?
by Zacks Equity Research
Community Health Systems' (CYH) fourth-quarter results are likely to reflect a higher occupancy rate and average length of stay.
Bullish SoFi (SOFI) Option Spread For Upside Catalysts Ahead
by Daniel Laboe
I'm looking at a bullish SOFI spread that will maximize upside potential and minimize upfront costs
Clover Health Investments, Corp. (CLOV) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Clover Health Investments, Corp. (CLOV) closed at $4.09, marking a -0.24% move from the previous day.
Is the Options Market Predicting a Spike in Clover Health (CLOV) Stock?
by Zacks Equity Research
Investors need to pay close attention to Clover Health (CLOV) stock based on the movements in the options market lately.
Implied Volatility Surging for Clover Health (CLOV) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Clover Health (CLOV) stock based on the movements in the options market lately.
Clover Health (CLOV) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Clover Health's (CLOV) third-quarter results are likely to benefit from Direct Contracting and strategic partnerships.
Clover Health Investments, Corp. (CLOV) Stock Moves -0.2%: What You Should Know
by Zacks Equity Research
Clover Health Investments, Corp. (CLOV) closed at $7.39 in the latest trading session, marking a -0.2% move from the prior day.
Clover Health Investments, Corp. (CLOV) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Clover Health Investments, Corp. (CLOV) closed the most recent trading day at $7.88, moving +1.42% from the previous trading session.
Clover Health Investments, Corp. (CLOV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Clover Health Investments, Corp. (CLOV) closed at $8.14, marking a -0.37% move from the previous day.
Do Options Traders Know Something About Clover Health (CLOV) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Clover Health (CLOV) stock based on the movements in the options market lately.
Clover Health (CLOV) Stock Rises on Impressive Q2 Revenues
by Zacks Equity Research
Share value of Clover Health (CLOV) hits through the roof on the back of a solid revenue and earnings outlook.
Implied Volatility Surging for Clover Health (CLOV) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Clover Health (CLOV) stock based on the movements in the options market lately.
Clover Health Investments, Corp. (CLOV) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Clover Health Investments, Corp. (CLOV) closed at $8.15 in the latest trading session, marking a +0.99% move from the prior day.
Clover Health Investments, Corp. (CLOV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Clover Health Investments, Corp. (CLOV) closed at $8.05, marking a -1.83% move from the previous day.
Clover Health Investments, Corp. (CLOV) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Clover Health Investments, Corp. (CLOV) closed at $8.20, marking a +1.86% move from the previous day.